Affiliations

• ¹ André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia brunoni@usp.br.
• ² André R. Brunoni, MD, PhD, Adriano H. Moffa, BS, Interdisciplinary Center for Applied Neuromodulation, University Hospital & Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, Laboratory of Neurosciences (LIM-27), University of São Paulo, São Paulo, Brazil; Felipe Fregni, MD, PhD, Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA; Ulrich Palm, MD, Frank Padberg, MD, PhD, Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany; Daniel M. Blumberger, MD, Zafiris J. Daskalakis, MD, Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada; Djamila Bennabi, MD, Emmanuel Haffen, MD, Department of Clinical Psychiatry, Clinical Investigation Center 1431 Inserm, EA 481 Neurosciences, University Hospital of Besancon and FondaMental Foundation, Créteil, France; Angelo Alonzo, PhD, Colleen K. Loo, MD, School of Psychiatry, University of New South Wales, Black Dog Institute and St George Hospital, Sydney, Australia.